Quality of life in head and neck cancer patients

Share :
Published: 29 Jul 2015
Views: 2525
Rating:
Save
Prof Fabio de Abreu Alves - AC Camargo Cancer Center, Sao Paulo, Brazil

Prof de Abreu Alves talks to ecancertv at IAOO 2015 about the merits of the congress and quality of life challenges in need of consideration in head and neck cancer.

Quality of life in head and neck cancer patients

Prof Fabio de Abreu Alves - AC Camargo Cancer Center, Sao Paulo, Brazil


In the congress I am President of the third Stomatological Congress of Brazil Society. Each year this congress is held in a different state of Brazil and this year we are organised together.

What are some of the challenges?

In general the dentists have two missions. The first mission is to diagnose the premalignant disorders. These lesions have the potential to become a cancer. Then if we diagnose this disease first we can do an initial diagnosis of cancer, we can prevent the cancer in our own mouth. Another mission – we take care of patients who have sore mouths related to oncological treatment like mucositis, another effect is xerostomia. We have the mission of integrating these oncological patients in society.

Have these treatments been well tolerated?

In most of the patients we have a good control of these oral side effects. It is interesting, some patients stop the oncological treatment because of these oral side effects like mucositis but in general most of the patients have good control of these oral side effects.

Any final thoughts on the congress?

This is the best congress already organised here in Brazil. Most people I have talked to are exciting and most are proud of organising this congress here in São Paulo. Then for us this is an excellent congress, the best congress of oral cancer here in Brazil, of course in the world.

Related Videos

CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC

Dr Renu Ragupathi - University Hospitals Dorset, Bournemouth, UK
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC ( Dr Renu Ragupathi - University Hospitals Dorset, Bournemouth, UK )
1 Nov 2024

Cancer in emergencies: What can we do better to protect the most vulnerable?

Prof Tezer Kutluk - Turkish Association for Cancer Research and Control, Ankara, Turkey
Cancer in emergencies: What can we do better to protect the most vulnerable? ( Prof Tezer Kutluk - Turkish Association for Cancer Research and Control, Ankara, Turkey )
23 Oct 2024

Reducing stigma for lung cancer and other smoking-related respiratory diseases

Mr Nathan Harrison - Flinders University, Adelaide, Australia
Reducing stigma for lung cancer and other smoking-related respiratory diseases ( Mr Nathan Harrison - Flinders University, Adelaide, Australia )
12 Sep 2023

Supporting breast cancer patients in Vietnam

Ms Thu Ha Hoang - Founder, Kien Cuong Cancer Support Club, Vietnam
Supporting breast cancer patients in Vietnam ( Ms Thu Ha Hoang - Founder, Kien Cuong Cancer Support Club, Vietnam )
4 Sep 2023

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer

Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer ( Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina )
28 Jun 2023

Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC

Dr Alberto Servetto - University of Naples Federico II, Naples, Italy
Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC ( Dr Alberto Servetto - University of Naples Federico II, Naples, Italy )
5 Apr 2023

Lung cancer screening and treatment in the Philippines

Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines
Lung cancer screening and treatment in the Philippines ( Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines )
4 Apr 2023

Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure

Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece
Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure ( Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece )
16 Mar 2023

How to avoid unnecessary second surgery in differentiated thyroid cancer

Dr Sarameth Thou - Calmette Hospital, Phnom Penh, Cambodia
How to avoid unnecessary second surgery in differentiated thyroid cancer ( Dr Sarameth Thou - Calmette Hospital, Phnom Penh, Cambodia )
10 Mar 2023